Arrangement for an individualized patient blood analysis

Abstract

The invention relates to an arrangement for an individualized patient blood analysis. The object of the present invention of specifying an arrangement for the individualized in vitro patient blood analysis, in particular for sepsis examinations, which avoids the disadvantages of the prior art and facilitates a meaningful examination result within 1 hour using only 1 to 2 ml of blood is achieved byvirtue of an arrangement for an individualized in vitro patient blood analysis being provided, said arrangement comprising a holography module (1), a Raman spectroscopy module (2), a biomarker module(3) and a flow control component (4), which are connected in a data and information transmitting manner to a central control and computer unit (5) connected in an information transmitting manner to adatabase (6), wherein the modules (1, 2 and 3) are connected by way of the flow control component (4) to a common blood sample supply (73) and further liquid material supplies (7) are fluidly connected.

Description

technical field [0001] The invention relates to a device for individualized patient blood analysis, in particular for sepsis research. Background technique [0002] According to the current state of the art, during clinical diagnosis large quantities of blood are drawn from the patient to be examined in order to subsequently carry out different analyzes of the blood, wherein the analyzes are often carried out at different laboratory benches or even in different laboratories . [0003] In the case of suspected infectious diseases, blood images are taken to detect the number and morphology of blood components of cells, tests are performed with the help of various specific biomarkers for qualitative and quantitative analysis of different infectious pathogens (of which, usually must Each biomarker is measured in a single test) and microbiological analysis is performed by culture and subsequent characterization of the pathogen. [0004] The disadvantage of the universal clinica...

AI Technical Summary

Problems solved by technology

[0004] The disadvantage of the universal clinical examination is that several individual tests have to be carried out, which require several milliliters of the patient's blood, which is moreover usually very time-consuming (microbiological test results are usually not available until 2 or several days later) and cannot provide All vital information (e.g. information on leukocyte activation status currently undetectable)

[0005] There is also no established simple systemic solution based on biomarkers that provides physicians with the complete desired amount of information

Images